Safety and effectiveness of a GENOSS stent in multiple blocked arteries
Part of Heart & circulation clinical trials.
This trial tests a new drug-coated stent (GENOSS® DES) for people with blockages in multiple heart arteries. It aims to see how safe and effective the stent is for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have coronary artery disease in more than one blood vessel (or a previous blockage that was treated)
- You received a GENOSS® drug-eluting stent during your angioplasty
- You agree to the study plan, follow-up visits, and sign a consent form
- If you are not a native Korean speaker, you must be fluent in Korean and understand Korean documents
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial tests whether a shorter course of dual antiplatelet therapy (two blood thinners) is safe and effective for people who have received a GENOSS stent for coronary artery disease. It aims to reduce the risk of bleeding while still preventing heart attacks.
This study tests whether taking two blood thinners for one year after getting a special GENOSS stent is safe and works well for people with coronary artery disease, especially if the stent placement was complex. The goal is to prevent blood clots and keep your artery open.
This trial compares two ways to open multiple blocked heart arteries: a special balloon coated with heart-protecting medicine versus a permanent stent (small mesh tube). The trial tests which approach works better for patients with blockages in multiple coronary arteries.
This study looks at how well doctors can treat multiple blocked heart arteries using a specific drug-eluting stent, aiming to fully open them. It may help patients whose blockage pattern fits the study, but it does not include certain high-risk or special cases.
This study tracks how well a newer heart stent (a small metal tube that keeps arteries open) works in real patients. Researchers want to understand if this specific stent design is safe and effective over time.
Hear when a new Percutaneous Coronary Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.